Opinion of Advocate General Sharpston delivered on 31 January 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision
Articles 4 to 10 set out the procedure relating to applications for the authorisation of a medicinal product. Applications are to be submitted to the European Medicines Agency established under the Regulation, [See Articles 1 and 4(1).] …
31 Jan 2013 · 62011CC0535
Opinion of Advocate General Saugmandsgaard Øe delivered on 25 July 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and OthersDecision
The exclusive power that Regulation No 726/2004 confers on the EMA in fact relates only to the evaluations carried out so that the Commission can issue the MA for a medicinal product. [See, in particular, Articles 5 to 9 of Regulation No …
25 Jul 2018 · 62017CC0029
Order of the President of the Court of First Instance of 24 April 2009. Nycomed Danmark ApS v Agence européenne des médicaments (EMEA).Decision
24 Apr 2009 · 62009TO0052
Regulation (EU) 2024/568Law
1. Inspections au titre de l’article 8, paragraphe 2, de l’article 19 et de l’article 57, paragraphe 1, point i), du règlement (CE) no 726/2004 et de l’article 126, paragraphe 2, du règlement (UE) 2019/6 1.1. Inspections …
Judgment of the Court (First Chamber) of 21 November 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and Others.Decision
Article 4 of the regulation lays down that applications for MA are to be submitted to the European Medicines Agency (EMA). The requirements for the submission and examination of those applications are set out in Articles 5 to 15 of the …
21 Nov 2018 · 62017CJ0029
Judgment of the General Court (Fifth Chamber), 4 July 2013. Laboratoires CTRS v European Commission.Decision
… τα στοιχεία και τα έγγραφα που προβλέπονται, ιδίως, στο άρθρο 8, παράγραφος 3, στο άρθρο 10α και στο παράρτημα I της οδηγίας 2001/83.
4 Jul 2013 · 62012TJ0301
Opinion of Advocate General Saugmandsgaard Øe delivered on 21 September 2017. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della CDecision
… 726/2004 face trimitere la informațiile prevăzute în special la articolul 8 alineatul (3) din această directivă. Mai ales litera (j) din această reglementare menționează RCP. Potrivit articolului 11 din directiva menționată, …
21 Sep 2017 · 62016CC0179
Judgment of the General Court (Tenth Chamber, Extended Composition) of 13 November 2024. Orion Oyj v European Commission.Decision
… in Article 10(2)(a), as ‘a medicinal product authorised under Article 6, in accordance with the provisions of Article 8 [of the same regulation]’. That abridged procedure exempts the party applying for marketing authorisation for the …
13 Nov 2024 · 62020TJ0223